Delayed diagnosis and racial bias in children with genetic conditions

Jacklyn Omorodion1,2,3, Leah Dowsett4,5, Robin D Clark6

  • 1Boston Combined Residency Program, Harvard Medical School, Boston, Massachusetts, USA.

Insights

Timely genetic diagnosis is crucial for pediatric patients, especially from minority populations. This study identifies factors causing delays and proposes solutions to reduce health disparities and improve access to genetic care for all children.

Area of Science:

  • Medical Genetics
  • Pediatric Health
  • Health Disparities

Background:

  • Increasing availability of genetic therapeutics necessitates prompt genetic diagnosis.
  • Delayed diagnosis of genetic conditions contributes to significant health disparities in pediatric populations.
  • Minority pediatric patients are disproportionately affected by diagnostic delays.

Purpose of the Study:

  • To examine health system, provider, and patient-level factors contributing to delayed genetic diagnosis in minority pediatric patients.
  • To identify root causes of health disparities in genetic care access.
  • To propose actionable strategies for improving equitable access to genetic diagnosis and care.

Main Methods:

  • Analysis of clinical cases involving pediatric patients from minority populations.
  • Examination of contributing factors at multiple levels: health system, provider, and patient.
  • Literature review on genetic diagnosis and health equity.

Main Results:

  • Identified key factors across health system, provider, and patient domains that impede timely genetic diagnosis.
  • Demonstrated a link between diagnostic delays and racial health disparities in pediatric genetic conditions.
  • Highlighted the urgent need for systemic interventions to ensure equitable care.

Conclusions:

  • Addressing systemic, provider, and patient-level barriers is essential for timely and equitable genetic diagnosis.
  • Interventions aimed at improving genetic care access for minority children can reduce health disparities.
  • Ensuring equitable access to genetic diagnosis is critical for the effective utilization of emerging genetic therapeutics.

Related Concept Videos

Genomic Imprinting and Inheritance02:30

Genomic Imprinting and Inheritance

Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
35.5K
Pedigree Analysis01:35

Pedigree Analysis

Overview
85.9K
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
792
Genetic Lingo01:11

Genetic Lingo

Overview
106.3K
Stereotypes, Prejudice, and Discrimination02:55

Stereotypes, Prejudice, and Discrimination

Humans are very diverse and although we share many similarities, we also have many differences. The social groups we belong to help form our identities (Tajfel, 1974). These differences may be difficult for some people to reconcile, which may lead to prejudice toward people who are different. Prejudice is a negative attitude and feeling toward an individual based solely on one’s membership in a particular social group (Allport, 1954; Brown, 2010). Prejudice is common against people who...
92.1K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
295